Fate and functional consequences of fetal antigen uptake by maternal circulating neutrophils and monocytes

Maternal circulating neutrophils ($Ly6G^{+}$ in mice, $CD15^{+}$ in humans) and monocytes ($F4/80^{+}$ in mice, $CD14^{+}$ in humans) take up fetus-derived antigen during the second half of pregnancy and acquire homeostatic phenotypes, but what happens to the antigen after uptake — and with what consequences for maternal-fetal tolerance — is unknown. The open problem is to determine, mechanistically and in vivo, whether these antigen-carrying innate cells sequester fetal antigen, transfer it to professional antigen-presenting cells in the uterine-draining lymph nodes for indirect presentation, or directly present processed fetal peptides to maternal T cells; to resolve the precise subset identities of the antigen-bearing cells, the receptor- and opsonin-mediated mechanisms by which placenta-derived particles are engulfed, and the composition of those particles; and to establish the functional consequences of antigen carriage for maternal T-cell responses, regulatory T-cell induction, and postpartum immunological memory. These hypotheses remain unresolved.

Background

The mammalian fetus expresses paternal antigens that make it a semi-allograft (a graft genetically half-foreign to the mother), yet it is usually tolerated for nine months. Most classical work on this maternal-fetal tolerance focused on the decidua (the immunologically specialized lining of the pregnant uterus) and the adjacent uterine-draining lymph nodes. However, fetal and placental material — including cell-free fetal DNA, intact trophoblast cells (the placenta's outer epithelial layer), and placenta-derived extracellular vesicles and particles — also enters the maternal bloodstream, reaching measurable concentrations as gestation progresses; the fate of this circulating fetal antigen was, until recently, largely unknown.

Arenas-Hernandez et al. (2022) addressed this gap with a mouse model in which transgenic males expressing chicken ovalbumin (OVA, a model antigen) under the beta-actin promoter were mated with allogeneic wild-type females, so that fetus-derived OVA could be tracked in the mother by flow cytometry and confocal microscopy. They identified fetus-derived antigen inside maternal circulating $Ly6G^{+}$ neutrophils and $F4/80^{+}$ mononuclear phagocytes (neutrophils are the most abundant circulating leukocyte; monocytes are circulating phagocytes that can migrate into tissues; $Ly6G$ and $F4/80$ are standard mouse surface markers for these lineages). These fetal antigen-carrying cells were most abundant in the second half of pregnancy and displayed homeostatic rather than inflammatory phenotypes: neutrophils up-regulated MHC-II (the major histocompatibility complex class II molecule that presents peptide antigens to CD4$^{+}$ T cells) and the co-stimulatory molecule CD80 while expressing little IFN$\gamma$ or TNF$\alpha$, and $F4/80^{+}$ cells up-regulated the co-stimulatory molecule CD86 and the immunosuppressive cytokines IL-10 and TGF-$\beta$. In vitro, maternal mouse $Ly6G^{+}$ and $F4/80^{+}$ cells, and $CD15^{+}$ neutrophils and $CD14^{+}$ monocytes from women in the second and third trimester, engulfed GFP-labeled placenta-derived particles, including cytotrophoblast-derived particles in the human case. Antigen-carrying cells persisted at least 48–60 h postpartum.

This established a new systemic arm of maternal-fetal crosstalk but left its mechanism unresolved. The authors stated the central question explicitly: three hypotheses could explain the uptake — (i) containment, in which phagocytes sequester fetal antigen to prevent aberrant antigen-specific maternal T-cell activation; (ii) transfer, in which the cells carry processed antigen to the uterine-draining lymph nodes for indirect presentation by professional antigen-presenting cells (APCs) such as dendritic cells; or (iii) direct presentation, in which neutrophils and monocytes themselves present processed fetal peptides on MHC molecules to maternal T cells in blood, lymphoid, or decidual tissue. The study's marker panel could not separate circulating monocytes from macrophages or monocyte subsets, the placenta-derived particles were not biochemically characterized, and no functional assay linked uptake to downstream adaptive immune outcomes. These gaps matter because pregnancy is known to imprint antigen-specific immunological memory on the mother — e.g., Rowe et al. (Nature, 2012) showed that pregnancy expands fetal-antigen-specific regulatory T cells (Tregs) that sustain anergy to fetal antigen and accumulate across successive pregnancies — so identifying which cells handle circulating fetal antigen, and how, bears directly on how systemic tolerance to fetal antigen is built and maintained.

Problem Statement

Determine, mechanistically and in vivo, what happens to fetus-derived antigen after its uptake by maternal circulating innate cells, and with what immunological consequences. Concretely: (1) distinguish among the three hypotheses proposed by Arenas-Hernandez et al. (2022) — that maternal $Ly6G^{+}$ neutrophils and $F4/80^{+}$ mononuclear phagocytes that have taken up placenta-derived antigen (a) sequester and contain it to limit fetal-antigen-specific maternal effector T-cell activation, (b) process and transfer it to professional antigen-presenting cells in the uterine-draining lymph nodes for indirect presentation, or (c) directly present processed fetal peptides on MHC molecules to maternal T cells in the circulation, lymphoid tissue, or decidua; (2) resolve the precise cellular identities of the antigen-bearing cells (circulating monocyte subsets versus macrophages, within the $F4/80^{+}$/$CD14^{+}$ populations); (3) define the molecular composition of the placenta-derived particles carrying fetal antigen and the receptor-mediated and opsonin-dependent mechanisms of their engulfment by maternal phagocytes; and (4) establish the functional consequences of antigen carriage — its effects on the cells' antigen-presentation capacity and migration to lymphoid tissue, on fetal-antigen-specific maternal T-cell and regulatory T-cell responses during pregnancy, and on postpartum innate memory. These four facets jointly serve one objective: an integrated account of how the maternal circulation handles fetal antigen and how this systemic pathway contributes to maternal-fetal tolerance. All four facets are mandatory: the task is resolved only when each of (1)–(4) is addressed, and a partial result that resolves facet (1) alone — or any other single facet — does not by itself resolve it. Facet (1) is the central hypothesis question, but the integrated account requires facets (2)–(4) as well.

References

1. Arenas-Hernandez M, Romero R, Gershater M, Tao L, Xu Y, Garcia-Flores V, Pusod E, Miller D, Galaz J, Motomura K, Schwenkel G, Para R, Gomez-Lopez N. Specific innate immune cells uptake fetal antigen and display homeostatic phenotypes in the maternal circulation. Journal of Leukocyte Biology 111(3):519-538, 2022. doi:10.1002/jlb.5hi0321-179rr. https://pmc.ncbi.nlm.nih.gov/articles/PMC8881318/
2. Boly TJ, Bermick JR. Maternal-fetal tolerance: Not just a uterine affair. Journal of Leukocyte Biology 111(3):515-517, 2022. doi:10.1002/JLB.5CE1021-560. https://pmc.ncbi.nlm.nih.gov/articles/PMC10200273/
3. Farias-Jofre M, Romero R, Galaz J, Xu Y, Tao L, Demery-Poulos C, Arenas-Hernandez M, et al. Pregnancy tailors endotoxin-induced monocyte and neutrophil responses in the maternal circulation. Inflammation Research 71(5-6):653-668, 2022. doi:10.1007/s00011-022-01569-z. https://pmc.ncbi.nlm.nih.gov/articles/PMC9021564/
4. Demery-Poulos C, Romero R, Xu Y, Arenas-Hernandez M, Miller D, Tao L, Galaz J, Farias-Jofre M, Bhatti G, Garcia-Flores V, Seyerle M, Tarca AL, Gomez-Lopez N. Pregnancy imparts distinct systemic adaptive immune function. American Journal of Reproductive Immunology 88(5):e13606, 2022. doi:10.1111/aji.13606. https://pmc.ncbi.nlm.nih.gov/articles/PMC9648024/
5. Garcia-Flores V, Romero R, Tarca AL, Peyvandipour A, Xu Y, Galaz J, Miller D, Chaiworapongsa T, Chaemsaithong P, Berry SM, Awonuga AO, Bryant DR, Pique-Regi R, Gomez-Lopez N. Deciphering maternal-fetal cross-talk in the human placenta during parturition using single-cell RNA sequencing. Science Translational Medicine 16(729):eadh8335, 2024. doi:10.1126/scitranslmed.adh8335. https://pmc.ncbi.nlm.nih.gov/articles/PMC11238316/
6. Winter HE, Murrieta-Coxca JM, Álvarez D, Henao-Restrepo J, Fuentes-Zacarías P, Arcila-Barrera S, Steiniger F, Groten T, Markert UR, Morales-Prieto DM. Enhanced capture of preeclampsia-derived extracellular vesicles from maternal plasma by monocytes and T lymphocytes. Journal of Reproductive Immunology 167:104417, 2025. doi:10.1016/j.jri.2024.104417. https://pubmed.ncbi.nlm.nih.gov/39709894/
7. Laskewitz A, Wekema L, Faas MM, Prins JR. Maternal immune characteristics at mid and late pregnancy are mostly independent of fetal allogeneity in mice. American Journal of Reproductive Immunology 93(6):e70089, 2025. doi:10.1111/aji.70089. https://pubmed.ncbi.nlm.nih.gov/40450670/
8. Gomez-Lopez N, Kareus E, Lee S. Immune cellular homeostasis and its breakdown at the maternal-fetal interface. Trends in Immunology 47(3):202-211, 2026. doi:10.1016/j.it.2025.11.006. https://pubmed.ncbi.nlm.nih.gov/41407649/
9. Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 490(7418):102-106, 2012. doi:10.1038/nature11462. https://pubmed.ncbi.nlm.nih.gov/23023128/